South and Central America Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)

TIPRE00028652 | Pages: 112 | Medical Device | Apr 2022 | Type: Regional | Status: Published

The South & Central America circulating tumor cell (CTC) diagnostics market is expected to reach US$ 214.0 million by 2028 from US$ 116.9 million in 2021. The market is estimated to grow at a CAGR of 9.0% from 2021 to 2028.

 

Health systems across the region are witnessing a substantial increase in the prevalence of cancer. Thus, the increased prevalence of cancer across South & Central America is propelling the demand for circulating tumor cell diagnostics. The analysis and detection of circulating tumor cells assist in early patient diagnosis, and the prognosis helps determine accurate treatment for these patient. The CTC diagnostics products  to detect various types of cancers, including prostate cancer, breast cancer, colorectal cancer, kidney cancer, lymphomas, lung cancer, and melanoma. There has been a high demand for CTC diagnostics in recent years due the reliability and accuracy of this technique in identifying the risk of various cancers and monitoring different cancer treatments.

 

Brazil, Argentina, Uruguay, Chile, Peru, and Colombia were hit by the second wave of corona infection. Brazil has registered the majority of deaths due to this disease in South and Central America. Moreover, COVID-19 impacted the number of patients undergoing cancer diagnosis, screening, and treatment. The havoc created by COVID-19 compelled majority of pharmaceutical and biotechnology companies to shift their focus on the development of novel therapies and diagnostics for this disease. Moreover, continuous strain due to the COVID-19 outbreak impacted supply chains, company operations, and distribution systems, including their R&D abilities, and novel product launches and services. Thus, the COVID-19 pandemic hampered the circulating tumor cell (CTC) diagnostics market in SCAM during the forecast period.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The South & Central America circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.

 

South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


 

South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

 By Technology

  • CTC detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis

By Application

  • Clinical/Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell and Tumorigenesis Research
    • Drug/Therapy Development

By End-User

  • Hospitals and Clinics
  • Research and Academic Institutes
  • Diagnostic Centers

By Country

  • Brazil
  • Argentina
  • Rest of South & Central America

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • Fluxion Bioscience

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– South & Central America Analysis

6.1         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.4     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.4.1       South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.4.2       South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.5     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6     South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       Brazil

10.1.6.1.1       Overview

10.1.6.1.2       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4.1     Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4.2     Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.5       Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2       Argentina

10.1.6.2.1       Overview

10.1.6.2.2       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4.1     Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4.2     Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.5       Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3       Rest of South and Central America

10.1.6.3.1       Overview

10.1.6.3.2       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4.1     Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4.2     Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.5       Rest of South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

11.        Impact of COVID-19 Pandemic on South & Central America Circulating Tumor Cell (CTC) Diagnostics Market

11.1      South & Central America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      FLUXION BIOSCIENCES

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 3.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 4.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 5.             South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 9.             Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 10.          Brazil: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 14.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 15.          Argentina: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/Liquid Biopsy– Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Research– Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by End-User– Revenue and Forecast to 2028 (US$ Million)

Table 21.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 22.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 23.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

 


LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           Brazil is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           South & Central America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           South & Central America Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        South & Central America Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        South and Central America: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 27.        Brazil: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Argentina: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest Of South And Central America: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in South & Central America Country Markets

Figure 31.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

 

  1. Thermo Fisher Scientific Inc.
  2. Stemcell Technologies Inc.
  3. Qiagen
  4. Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  5. Fluxion Biosciences
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America circulating tumor cell (CTC) diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America circulating tumor cell (CTC) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000